What is CAP?

Founded in 1993, the Corporate AACE Partnership (CAP) is a forum whose purpose is to develop and nurture an open dialogue between industry and our association to advance patient care. The mission of the CAP is to facilitate the improvement of endocrine patient care by working with industry in areas of mutual interest.
Current Partners
Abbott Diabetes Care
AbbVie
Amgen
Amryt
AstraZeneca
Bayer
Bigfoot Biomedical
Boehringer Ingelheim Pharmaceuticals, Inc.
Corcept Therapeutics
Dexcom, Inc.
Diabeloop
Health Monitor Network
Horizon Therapeutics
Laboratory Corporation of America
Lifescan
Lilly Diabetes
Mannkind Corporation
Medtronic, Inc
Merck-Pfizer Diabetes Collaboration
Novo Nordisk
Pfizer
Quest Diagnostics
Radius Health
Recordati Rare Diseases
Sandoz
Siemens
Takeda Pharmaceuticals U.S.A, Inc.
Vertex Pharmaceuticals
Xeris Pharmaceuticals
To learn more about the CAP or to request more details about joining the CAP, e-mail [email protected].